Active Specific Immunotherapy: To start Phase I trial

Cellcor Inc. (CLTX), Newton, Mass. Organon Teknika/Biotech Research Institute, Rockville, Md. Product: Active Specific Immunotherapy, an autologous tumor cell/Bacillus Calmette-Guerin vaccine develop...